Lupus 2018-08
Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus.
Abstract
Background The role of sleep in the etiology of systemic lupus erythematosus (SLE) has not been well studied. We examined whether sleep duration was associated with subsequent transitioning to SLE in individuals at risk for SLE. Methods Four hundred and thirty-six relatives of SLE patients who did not have SLE themselves at baseline were evaluated again an average of 6.3 (± 3.9) years later. Fifty-six individuals transitioned to SLE (≥ 4 cumulative American College of Rheumatology (ACR) criteria). Sleep duration, medication use and medical history were assessed by questionnaire; ACR criteria were confirmed by medical record review. Vitamin D was measured by ELISA. Generalized estimating equations, accounting for correlation within families, assessed associations between baseline sleep and the outcome of transitioning to SLE. Results Reporting sleeping less than 7 hours per night at baseline was more common in those who subsequently transitioned than those who did not transition to SLE (55% versus 32%, p = 0.0005; OR: 2.8, 95% CI 1.6-4.9). Those who transitioned to SLE were more likely to sleep less than 7 hours per night than those who did not transition to SLE adjusting for age, sex and race (OR: 2.8, 95% CI 1.6-5.1). This association remained after individual adjustment for conditions and early symptoms that could affect sleep, including prednisone use, vitamin D deficiency and number of ACR criteria (OR: 2.0, 95% CI 1.1-4.2). Conclusion Lack of sleep may be associated with transitioning to SLE, independent of early clinical manifestations of SLE that may influence sleep duration. Further evaluation of sleeping patterns and biomarkers in at-risk individuals is warranted.
Related Questions
Do you recommend Vitamin D and omega 3 fatty acid supplementation for prevention of autoimmune disease?
A resounding "Yes!" but with caveats. I do not recommend them independently but as part of a list of recommendations (listed below).There is mounting data that many autoimmune disorders (especially systemic lupus erythematosus, SLE, and rheumatoid arthritis) probably occur due to environmental (exte...
What is your approach to monitoring a patient with SLE who has persistent hypocomplementemia on hydroxychloroquine, but clinically has resolution of cutaneous symptoms and no other internal organ manifestations of disease?
Per the subtitle under your question, an undetectable C4 with low C3 makes me wonder about the possibility of a homozygous C4 deficiency, of whom 75-80% of patients have SLE with a high occurrence of lupus nephritis (Yang et al., PMID 15294999). You can consider genetic testing (primarily for geneti...